Change in Management

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 15 July 2026 Corporate relationship Department, National Stock Exchange of India, Limited BSE Limited, Exchange Plaza, 5th Floor, 1st Floor, Rotunda Building Plot No. C/1, G Block, Bandra-Kurla Complex, P.J Towers Dalal Street, Fort, Bandra (E), Mumbai 400001 Mumbai 400051 Stock Code: BSE – 53054 / NSE – SHILPAMED Dear Sir/Ma’am, Sub: Resignation of Dr. Sridevi Khambhampaty as CEO of Shilpa Biologicals Pvt ltd Reg: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Please find enclosed herewith requisite disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with respect to Dr. Sridevi Khambhampaty, as Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited, a material subsidiary of Shilpa Medicare Limited, vide her letter dated 15 April 2026, resigned from the position of CEO of Shilpa Biologicals Private Limited with effect from closing hours of 15 July 2026, due to her personal commitments. The requisite details as prescribed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated 30th January 2026, are enclosed herewith as Annexure A. This is for your information and records. Thanking you, For Shilpa Medicare Limited Ritu Tiwary Company Secretary & Compliance Officer Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Disclosure of events and information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Master Circular No. HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated 30th January 2026. ANNEXURE - A Name of Director / Senior Managerial Personnel Dr. Sridevi Khambhampaty Reason for Change viz. appointment, Resignation as the Chief Executive Officer of Shilpa reappointment, resignation, removal, death or Biologicals Private Limited, a material subsidiary of otherwise Shilpa Medicare Limited, due to personal reasons (Resignation Letter enclosed). Date of Appointment/ reappointment From closing hours of 15 July 2026. /cessation (as applicable) 15A pr2i0l2 6 TheB oaorfdD irectors ShilBipoal oPgviLtct adl s RespeBcotaeMrded m bers, Thanyko fuo trh weo ndeorpfpuolr ttuosn eirtavyste h CeE Of oSrh ilBpiao loagnidtco ab leas parotft hSeh Ipi af amiIhl ayv.te h orouegnhjlowyyo erdk wiinttghh t ee aamtt hSeh iBlipoal ogicals beautfiafcuiallt Di htayr waanddI a ms urteh atth iwsi lfllo uirnit shhBe i olobguiscisn ess. Unfortudnuatetop e ulrype,el rys orneaals Ioh nasvc,eh osteomn o voen a nadm h ererbeys igning frommy r olIwe i.bl els ervmiynn go tipceer iaospd e trh ceo mpapnoyl aincwdyo ulldit koeb e relioenvt ehcdel oshionugor fs1 5thJ u2l0y2 6. Myb eswti shfeoSsrh I pi aB ioloagniydco aulkrsi nsdew lifal llw aryesm ain. Kinrde gards SridKehvaim bhampaty